Skip to main content
. 2018 May 15;16(1):71–80. doi: 10.5114/aoms.2018.75678

Table I.

Demographic and basic parameters of the patient cohort at enrollment

Parameters Non-survivors (total n = 156) Survivors (total n = 413) P-value
Age (n = 114 vs. 381) 72.87 ±0.87 64.37 ±0.65 < 0.01
Gender (n; female/male) 53/103 110/303 0.096
BMI (n = 97 vs. 322) 27.03 ±0.55 27.60 ±0.26 0.32
GGT (n = 156 vs. 411) 70.54 ±9.0 46.20 ±2.50 < 0.01
AST (n = 155 vs. 413) 161.63 ±41.72 66.05 ±5.64 < 0.01
ALT (n = 156 vs. 413) 93.07 ±24.43 39.50 ±3.14 < 0.01
Bilirubin (n = 152 vs. 385) 0.65 ±0.03 0.65 ±0.02 0.95
CRP (n = 152 vs. 401) 4.72 ±0.51 1.58 ±0.14 < 0.01
Creatinine (n = 154 vs. 407) 1.64 ±0.08 1.33 ±0.04 < 0.01
Urea (n = 154 vs. 406) 29.48 ±1.34 20.47 ±0.74 < 0.01
eGFR (n = 113 vs. 378) 49.60 ±1.87 61.41 ±0.91 < 0.01
Troponin (n = 155 vs. 408) 13.28 ±2.32 7.58 ±0.98 < 0.01
Myoglobin (n = 146 vs. 381) 639.29 ±132.78 301.60 ±31.97 < 0.01
STEMI 27 (26.7%)1 91 (27.5%)1 1F
NSTEMI 74 (73.3%)1 240 (72.5%)1
Ex-/smoker (n = 100 vs. 324) 12/15 (12%/15%) 80/92 (24.7%/28.4%) χ2: < 0.01
Type 2 diabetes 28 (27.7% of n = 101) 108 (33.4% of n = 323) 0.3F
Hypercholesterolemia 73 (73% of n = 100) 272 (83.6% of n = 325) 0.0196F
RR systolic (n = 97 vs. 324) 127.4 134.6 0.01
RR diastolic (n = 97 vs. 324) 63.4 66.3 0.1
Heart rate (n = 80 vs. 284) 80.9 75.9 0.06
Family history 18 (18.2% of n = 99) 108 (33.5% of n = 322) < 0.01F

Continuous data are presented as mean ± SEM, categorical data as absolute numbers. Comparison between survivors and non-survivors by Student’s t test (continuous data) and Fisher’s exact test/χ2 (categorical data). ALT – alanine transaminase, AST – aspartate transaminase, BMI – body mass index, CRP – C-reactive protein, eGFR – estimated glomerular filtration rate, GGT – γ-glutamyl transferase.

1

Percentages of 101 non-survivors and of 331 survivors with known STEMI/NSTEMI

F

tested with Fisher’s exact test.